Bioptix Inc news

   Watch this stock
Showing stories 1 - 10 of about 55   

Articles published

BIOP 3.97 +0.03 (0.76%)
price chart
3.94
Bioptix Inc. BiOptix, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult ...
Bioptix Reports Board of Director Changes
BOULDER, Colo., Jan. 6, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP), (the "Company"), announced that Gail Schoettler, Susan Evans and David Welch have resigned from the Company's Board of Directors.
Bioptix Announces Executive Leadership Change
CASTLE ROCK, Colo., April 10, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP) ("Bioptix" or the "Company"), announced that its board of directors has appointed Michael M. Beeghley as chief executive officer effective as of April 6, 2017.
Bioptix, Inc (BIOP) Names Michael M. Beeghley as CEO  StreetInsider.com
Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to ...
BOULDER, Colo., Dec. 8, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced that following the approval from shareholders at the 2016 Annual Meeting of Shareholders of the proposal to change the Company's name, the Company's name has ...
Venaxis (APPY) Changes Name to Bioptix; Will Trade Under Ticker 'BIOP'  StreetInsider.com
BRIEF-Bioptix announces executive leadership change
bioptix Inc - has appointed Michael M. Beeghley as chief executive officer effective as of April 6, 2017. * Bioptix Inc - Beeghley succeeds Steve Lundy Source text for Eikon: Further company coverage: Our Standards: The Thomson Reuters Trust Principles ...
Bioptix Announces Streamlining of Workforce
20, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP) ("Bioptix" or the "Company"), announced that on January 14, 2017 the Board of Directors of the Company adopted a plan under which the Company will terminate certain employees associated with the ...
Honig Is Buying Again: This Time, Bioptix Inc. (NASDAQ:BIOP)
Barry Honig is one of the biotech space's most renowned entrepreneurs and investors. Along with his compatriot, Dr. Phillip Frost, he has been responsible for some of the big name successes in the sector.
BRIEF-Bioptix says Stephen Lundy resigned as chief executive officer
Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news ...
Venaxis Announces Acquisition of BiOptix
13, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced today that it has acquired BiOptix Diagnostics, Inc., ("BiOptix") a Boulder, CO-based privately-held company. BiOptix has developed a proprietary Enhanced Surface Plasmon Resonance ...
Bioptix, Inc. (NasdaqCM:BIOP): A Look Into the Volatility & Valuation
Watching some historical volatility numbers on shares of Bioptix, Inc. (NasdaqCM:BIOP), we can see that the 12 month volatility is presently 67.476400.